These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 9538133
1. Fibroblast growth factor-2 and -9 regulate proliferation and production of matrix metalloproteinases in human gliomas. Miyagi N, Kato S, Terasaki M, Shigemori M, Morimatsu M. Int J Oncol; 1998 May; 12(5):1085-90. PubMed ID: 9538133 [Abstract] [Full Text] [Related]
2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J. J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [Abstract] [Full Text] [Related]
3. Fibroblast growth factor-9 (glia-activating factor) stimulates proliferation and production of glial fibrillary acidic protein in human gliomas either in the presence or in the absence of the endogenous growth factor expression. Miyagi N, Kato S, Terasaki M, Aoki T, Sugita Y, Yamaguchi M, Shigemori M, Morimatsu M. Oncol Rep; 1999 Aug; 6(1):87-92. PubMed ID: 9864407 [Abstract] [Full Text] [Related]
4. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M. Int J Cancer; 1999 Jul 19; 82(2):274-81. PubMed ID: 10389763 [Abstract] [Full Text] [Related]
6. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression. Hur JH, Park MJ, Park IC, Yi DH, Rhee CH, Hong SI, Lee SH. J Korean Med Sci; 2000 Jun 19; 15(3):309-14. PubMed ID: 10895974 [Abstract] [Full Text] [Related]
8. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K, Ito A. Biol Reprod; 2003 Apr 19; 68(4):1276-81. PubMed ID: 12606436 [Abstract] [Full Text] [Related]
9. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS. Cancer Res; 1996 Jan 15; 56(2):384-92. PubMed ID: 8542596 [Abstract] [Full Text] [Related]
10. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas. Groft LL, Muzik H, Rewcastle NB, Johnston RN, Knäuper V, Lafleur MA, Forsyth PA, Edwards DR. Br J Cancer; 2001 Jul 06; 85(1):55-63. PubMed ID: 11437402 [Abstract] [Full Text] [Related]
11. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T. Br J Cancer; 1998 Jun 06; 77(12):2239-45. PubMed ID: 9649139 [Abstract] [Full Text] [Related]
12. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y. J Neurosurg; 1994 Jul 06; 81(1):69-77. PubMed ID: 8207529 [Abstract] [Full Text] [Related]
13. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, Grogan T, Marquez LA, Janowska-Wieczorek A. Blood; 1999 Sep 15; 94(6):2080-9. PubMed ID: 10477738 [Abstract] [Full Text] [Related]
14. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC. Biochem J; 1996 Apr 01; 315 ( Pt 1)(Pt 1):335-42. PubMed ID: 8670128 [Abstract] [Full Text] [Related]
15. Production of gelatinases and tissue inhibitors of matrix metalloproteinases by equine ovarian stromal cells In vitro. Song L, Porter DG, Coomber BL. Biol Reprod; 1999 Jan 01; 60(1):1-7. PubMed ID: 9858479 [Abstract] [Full Text] [Related]
16. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, Keski-Oja J, Saarialho-Kere UK. Br J Cancer; 1999 May 01; 80(5-6):733-43. PubMed ID: 10360651 [Abstract] [Full Text] [Related]
17. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Mäkelä M, Larjava H, Pirilä E, Maisi P, Salo T, Sorsa T, Uitto VJ. Exp Cell Res; 1999 Aug 25; 251(1):67-78. PubMed ID: 10438572 [Abstract] [Full Text] [Related]
18. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Tonn JC, Kerkau S, Hanke A, Bouterfa H, Mueller JG, Wagner S, Vince GH, Roosen K. Int J Cancer; 1999 Mar 01; 80(5):764-72. PubMed ID: 10048980 [Abstract] [Full Text] [Related]
19. Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility. Arato-Ohshima T, Sawa H. Int J Cancer; 1999 Oct 29; 83(3):387-92. PubMed ID: 10495432 [Abstract] [Full Text] [Related]
20. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. Qin H, Moellinger JD, Wells A, Windsor LJ, Sun Y, Benveniste EN. J Immunol; 1998 Dec 15; 161(12):6664-73. PubMed ID: 9862695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]